Penumbra, Inc. (NYSE:PEN - Get Free Report) EVP Johanna Roberts sold 900 shares of the business's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $298.55, for a total transaction of $268,695.00. Following the transaction, the executive vice president now directly owns 65,314 shares in the company, valued at approximately $19,499,494.70. The trade was a 1.36% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website.
Johanna Roberts also recently made the following trade(s):
- On Thursday, April 24th, Johanna Roberts sold 600 shares of Penumbra stock. The stock was sold at an average price of $300.01, for a total transaction of $180,006.00.
- On Tuesday, April 1st, Johanna Roberts sold 600 shares of Penumbra stock. The shares were sold at an average price of $269.11, for a total transaction of $161,466.00.
- On Monday, March 3rd, Johanna Roberts sold 600 shares of Penumbra stock. The stock was sold at an average price of $287.43, for a total transaction of $172,458.00.
Penumbra Price Performance
Shares of Penumbra stock traded down $0.41 during trading on Tuesday, hitting $281.16. The stock had a trading volume of 62,768 shares, compared to its average volume of 438,688. The business has a fifty day moving average of $279.66 and a two-hundred day moving average of $264.29. Penumbra, Inc. has a fifty-two week low of $148.00 and a fifty-two week high of $310.00. The firm has a market cap of $10.89 billion, a P/E ratio of 826.93, a PEG ratio of 2.83 and a beta of 0.53. The company has a debt-to-equity ratio of 0.02, a current ratio of 6.01 and a quick ratio of 3.25.
Penumbra (NYSE:PEN - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The company reported $0.83 earnings per share for the quarter, beating analysts' consensus estimates of $0.66 by $0.17. Penumbra had a return on equity of 9.74% and a net margin of 1.17%. The business had revenue of $324.14 million during the quarter, compared to analyst estimates of $315.72 million. During the same quarter last year, the company posted $0.41 EPS. Penumbra's revenue for the quarter was up 16.3% on a year-over-year basis. On average, sell-side analysts expect that Penumbra, Inc. will post 3.67 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several brokerages recently weighed in on PEN. Canaccord Genuity Group boosted their price objective on Penumbra from $323.00 to $340.00 and gave the company a "buy" rating in a report on Wednesday, February 19th. JPMorgan Chase & Co. boosted their price target on Penumbra from $230.00 to $285.00 and gave the company an "overweight" rating in a report on Wednesday, February 19th. Piper Sandler restated an "overweight" rating and set a $330.00 price objective (up from $250.00) on shares of Penumbra in a research note on Wednesday, February 19th. Stifel Nicolaus set a $318.00 price objective on shares of Penumbra and gave the stock a "buy" rating in a report on Thursday, April 24th. Finally, Needham & Company LLC reissued a "hold" rating on shares of Penumbra in a report on Wednesday, February 19th. Three research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $302.40.
Read Our Latest Stock Report on PEN
Hedge Funds Weigh In On Penumbra
Several institutional investors and hedge funds have recently modified their holdings of PEN. Bayforest Capital Ltd grew its stake in Penumbra by 35.9% in the first quarter. Bayforest Capital Ltd now owns 1,431 shares of the company's stock valued at $383,000 after purchasing an additional 378 shares in the last quarter. Woodline Partners LP grew its stake in shares of Penumbra by 476.1% in the 1st quarter. Woodline Partners LP now owns 145,881 shares of the company's stock valued at $39,010,000 after buying an additional 120,558 shares in the last quarter. United Services Automobile Association acquired a new position in Penumbra in the first quarter worth approximately $656,000. EFG Asset Management North America Corp. lifted its stake in shares of Penumbra by 24.6% in the 1st quarter. EFG Asset Management North America Corp. now owns 18,519 shares of the company's stock valued at $4,953,000 after purchasing an additional 3,659 shares during the last quarter. Finally, PDT Partners LLC boosted its stake in shares of Penumbra by 30.8% during the 1st quarter. PDT Partners LLC now owns 15,076 shares of the company's stock worth $4,031,000 after acquiring an additional 3,546 shares in the last quarter. 88.88% of the stock is currently owned by hedge funds and other institutional investors.
Penumbra Company Profile
(
Get Free Report)
Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.
Featured Articles

Before you consider Penumbra, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Penumbra wasn't on the list.
While Penumbra currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.